Silexion Therapeutics (SLXN) Misses Q1 EPS by 85c

Silexion Therapeutics (NASDAQ: SLXN) reported Q1 EPS of ($0.85).

For earnings history and earnings-related data on Silexion Therapeutics (SLXN) click here.

You May Also Be Interested In

• Samsara Inc (IOT) call put ratio 4.5 calls to 1 put with a focus on September 4 weekly calls into quarter results
• Bernstein SocGen on DoorDash Inc. (DASH): 'What now for the stock?'
• Victoria's Secret & Co. (VSXY) Tops Q2 EPS by 20c ; Offers Guidance